AIHEMAF–P: An Innovative Healthcare Model for Atrial Fibrillation Patients
2024

Innovative Healthcare Model for Atrial Fibrillation Patients

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): La Regina Raffaele, Innelli Pasquale, Glisenti Fulvio, Bollani Gianbattista, Leopardi Eugenio, Gensini Gian Franco, Nodari Savina, La Regina Giuseppe, La Regina Micaela, Gabbrielli Francesco, Schommer Jon

Primary Institution: Farmacia La Regina, San Rufo, Italy

Hypothesis

Can a smart clinic model involving community pharmacists improve the management of atrial fibrillation patients?

Conclusion

The study demonstrates that community pharmacists can effectively manage atrial fibrillation patients, improving adherence to therapy and monitoring outcomes.

Supporting Evidence

  • Compliance with planned checks was 93%.
  • Adherence to anticoagulant therapy was found to be 98%.
  • Major hemorrhagic events were reported in 13% of the sample, detected through close monitoring.

Takeaway

This study shows that pharmacists can help patients with heart problems by checking their health and making sure they take their medicine correctly.

Methodology

The study was observational, prospective, and involved a smart clinic model where pharmacists acted as case managers for atrial fibrillation patients.

Potential Biases

Potential biases due to the observational nature and lack of a control group.

Limitations

The study lacked a control group, making it difficult to attribute results solely to the innovative model.

Participant Demographics

46% women, mean age 71.22 years, 20% lived alone, 54% not independent in managing treatment.

Digital Object Identifier (DOI)

10.3390/pharmacy12060187

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication